SAN DIEGO — The University of California, San Diego has paused at least five clinical trials designed to cure or control HIV ...

Young people living with HIV in South Africa achieve high viral suppression rates on long-acting injectable antiretroviral therapy, and all who finished the study chose to continue treatment.

Historically, the United States has played a major role in funding HIV prevention and treatment abroad through programs like PEPFAR, the President's Emergency Plan for AIDS Relief. But in his second ...

UC San Diego has paused at least five clinical trials designed to cure or control HIV after the National Institutes of Health issued guidance last week that new enrollments should be put on hold. The ...

OPINION: New tools can transform HIV prevention and treatment. Their reach depends on confronting the barriers that keep people from care.

Gilead's twice-yearly shot reduced HIV infections by 96% in a second large study, the company said. The data sets the stage for likely FDA approval of lenacapavir for HIV prevention. Shares rose 3% in ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. A new sequential immunization strategy shows strong promise for an HIV vaccine, a ...

Patients with HIV who had frequent outpatient psychiatric visits and poor viral control faced a significantly higher likelihood for hospital admission.

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. NAKURU, KENYA - 2026/03/26: A healthcare worker fills a syringe with a dose of lenacapavir, ...

In the early decades of the global response to HIV/AIDS, the focus was on saving lives. And rightly so: without antiretroviral treatment (ART), people lived less than a year, on average, from the time ...

Scientific advances and effective treatment regimens have transformed HIV from the “near-certain death sentence” it represented in the 1980s to a chronic disease. Today, people with HIV (PWH) have a ...